News | Proton Therapy | January 27, 2017

Orlando Health and Mevion Offer Advanced Diagnostic Image Guidance for Proton Therapy

Mevion integrates in-room CT imaging to its Verity Patient Positioning System for the Mevion S250 at UF Health Cancer Center - Orlando Health

Mevion S250 proton therapy system, UF Health Cancer Center - Orlando Health, Airo CT scanner, Veritiy Patient Positioning System, radiation therapy

January 27, 2017 — Mevion Medical Systems and UF Health Cancer Center - Orlando Health recently announced the first patient treatment on a Mevion S250 proton therapy system in conjunction with Airo, a mobile, diagnostic computed tomography (CT) scanner. The advanced 3D CT-based localization is integrated to Verity Patient Positioning System, a component of the Mevion S250 Series, and is based on high-precision stereotactic localization and tracking technology. This solution improves treatment accuracy and reduces patient positioning uncertainties.

Orlando Health has been a pioneer in the implementation of image-guided radiation therapy (IGRT). The Mevion S250 is the first compact proton therapy system to integrate an in-room CT scanner for high-precision positioning and adaptive treatment, according to the company. CT imaging provides superior, high-resolution images that can be used for both positioning and adaptive treatment.

Orlando Health treated its first patient using a Mevion S250 in April 2016, and in less than four months was treating more than 20 patients per day thanks to the system’s fast ramp-up time, high throughput rate and low operating costs. Additionally, the Mevion S250 Series is capable of treating a wide variety of complex cases in adult and pediatric patients. In Orlando, it has treated tumors of the central nervous system (CNS), head and neck, breast, spine and other sensitive locations.

“Proton therapy is the most advanced treatment in radiation therapy and has allowed us to significantly reduce harmful radiation to healthy tissue, which is especially important for cancers near sensitive, hard-to-reach locations, both in children and adults,” said Naren R. Ramakrishna, M.D., Ph.D., director of neurologic and pediatric radiation oncology at Orlando Health. “Integrating proton therapy within our cancer center has given us the ability to provide a comprehensive range of services, allowing us to keep our patients in our system to receive the best treatment possible. In-room diagnostic CT imaging for positioning and treatment adaptation allows us to provide the most accurate treatment localization with protons.”

“This is an advancement in how we can precisely position patients for proton therapy compared to conventional planar imaging methods,” explained Omar Zeidan, Ph.D., chief of proton therapy physics at Orlando Health. “This CT-based IGRT system offers superior stereotactic localization with submillimeter accuracy in addition to the capability for adaptive proton therapy.”

For more information: www.mevion.com

Related Content

News | Prostate Cancer | October 22, 2018
The first report of a large, international clinical trial shows that, for men who show signs of...

Image courtesy of Vital Images

News | ASTRO | October 22, 2018
Treatment of renal cell carcinoma with stereotactic radiation therapy is as safe and effective for patients with one
DCIS, ductal carcinoma in situ, radiation therapy, survival benefit, Brigham and Women's Hospital study

Image courtesy of Barco

News | ASTRO | October 21, 2018
A subset of patients with low-risk breast cancer is highly unlikely to see cancer return following breast conservatio
The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. #ASTRO2018 #ASTRO #ASTRO18

The Aquilion Precision CT system from Canon offers very high resolution imaging, which may aid in cancer detection and improved treatment planning in radiation oncology. 

News | Computed Tomography (CT) | October 19, 2018
October 19, 2018 – At the 2018 American Society of...
IBA's Proteus system and proton therapy solutions will be discussed at ASTRO 2018. #ASTRO18 #ASTRO #ASTRO2018
News | Proton Therapy | October 19, 2018
October 19, 2018 – IBA (Ion Beam Applications S.A.) is sharing how hospitals can secure performance, investment and t
IBA Dosimetry Enters Interoperability Agreement With Varian for Dolphin Monitoring
News | Radiation Therapy | October 17, 2018
IBA (Ion Beam Applications S.A.) announced it has entered into an agreement with Varian with the goal of validating the...
Boston Scientific Closes Acquisition of Augmenix Inc.
News | Prostate Cancer | October 17, 2018
Boston Scientific Corp. announced the close of its acquisition of Augmenix Inc., developer of the SpaceOAR Hydrogel...
Varian Expands Cancer Care Portfolio With Noona Healthcare Acquisition
News | Patient Engagement | October 15, 2018
Varian announced the acquisition of privately-held software company Noona Healthcare, developer of a cloud-based,...
New Guideline for Prostate Cancer Supports Shortened Radiation Therapy
News | Prostate Cancer | October 12, 2018
Three prominent medical societies issued a new clinical guideline for physicians treating men with early-stage prostate...